Dr. Marianna Prokopi-Demetriades is a biotech innovator, entrepreneur, and Clin.Assoc.Professor in Research Oncology, known for her pioneering contributions to improving oncology patient care. 

She is the cofounder of three biotech enterprises, including RSL Revolutionary Labs Ltd, which is at the forefront of creating dermaceuticals that address the side effects of cancer treatments. Her work with Promed Bioscience Ltd is revolutionizing the bioprinting of artificial organs by developing biomaterials based on 3D-atelocollagen, and Theramir Ltd is pioneering precise cancer treatments through the synergy of nanotechnology and microRNAs. 

Her achievements have earned her the Forbes 20WomenInTech Award Cyprus 2023, the TechIsland Award Rising Star 2023, and recognition as a significant contributor to STEM at King’s College London among other accolades in 2022. The Republic of Cyprus recognized her with the Young Researcher Award in Life Sciences 2021, and she received the Madame Figaro Woman of the Year in Innovation Award in 2020. 

Her influence extends beyond the lab; she holds the prestigious CIM Honorary Fellow title from the Cyprus Institute of Marketing, acknowledging her significant economic impact on the region. Committed to continuous professional development, she has further enriched her leadership skills with Executive Education in Transformational Leadership from the University of Cambridge, Judge Business School in 2023. 

Her passion for mentorship is reflected in her involvement with numerous boards and initiatives such as ENAVSMA Foundation, ICC Women Network Cyprus, and mentoring roles with ARIS/Deloitte, JA Junior Achievement Cyprus, among others, The STEAM Academy, Falling Walls Female Science Talents, and the King’s Leadership Mentoring Programme.